Efficacy of CDK4/6i in preclinical models of malignant pleural mesothelioma
Assessment of antitumor activity of CDK4/6 inhibitors using in vitro and in vivo preclinical models of MPM using RNA-sequencing. We also include the genomic characterization (whole exome sequencing) of patient-derived cell lines used in the in vitro experiments.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001007737 | Illumina HiSeq 4000 | 12 | |
EGAD00001007738 | Illumina HiSeq 4000 | 10 | |
EGAD00001007739 | Illumina HiSeq 4000 | 17 |
Publications | Citations |
---|---|
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.
Br J Cancer 125: 2021 1365-1376 |
10 |